January 9, 2013 / 10:47 PM / in 5 years

St Jude Medical says fourth-quarter results to exceed forecast

(Reuters) - St. Jude Medical Inc STJ.N said on Wednesday that fourth-quarter profit would exceed its earlier forecast, as well as current Wall Street expectations, helped by cost-cutting measures.

St. Jude shares rose nearly 2 percent in extended trading.

The medical device maker said it now expects to report earnings of 90 to 92 cents per share, excluding items, and net sales of about $1.37 billion for the quarter. The profit would exceed its previous forecast by 2 to 4 cents. Analysts on average are looking for a profit of 87 cents per share, according to Thomson Reuters I/B/E/S.

The adjusted earnings exclude 50 to 60 cents per share related to restructuring and other charges, the company said.

St. Jude issued the preliminary results in conjunction with a presentation by Chief Executive Daniel Starks at the annual JP Morgan Healthcare Conference in San Francisco.

It said fourth-quarter sales in cardiac rhythm management products - its largest unit - fell 6 percent to $682 million.

The heart device maker is scheduled to report full fourth-quarter results on January 23.

St. Jude shares rose to $38.01 in after-hours trading from a New York Stock Exchange close at $37.30

Reporting by Bill Berkrot; editing by Matthew Lewis

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below